TRUFILL® n-BCA Liquid Embolic System is a safe, proven and effective treatment of Arteriovenous Malformations (AVMs). Since 2000, over 15,000 patients have been treated with the TRUFILL n-BCA Liquid Embolic System.1
The TRUFILL n-BCA Liquid Embolic System offers:
During its clinical trial, the TRUFILL n-BCA Liquid Embolic System was found to have equivalency in safety and efficacy compared with PVA embolization particles in achieving vascular occlusion.1
The TRUFILL n-BCA Liquid Embolic System is fully compatible with the full line of PROWLER
TRUFILL n-BCA Liquid Embolic System is available only in the United States and Costa Rica.
1 N-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial, AJNR 23: 748-755, May 2002
All medical devices have associated risks. Please refer to the package insert and other labeling for a complete list of indications, contraindications, precautions and warnings. For further information on DePuy Synthes Products, please contact your local DePuy Synthes Representative.